Kala Bio, Inc. (KALA)
0.7861
-0.05
(-6.23%)
USD |
NASDAQ |
Dec 09, 16:00
0.775
-0.01
(-1.41%)
After-Hours: 20:00
Kala Bio Shareholders Equity (Quarterly): -8.665M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Q32 Bio, Inc. | -18.45M |
| PharmaCyte Biotech, Inc. | 43.59M |
| Allogene Therapeutics, Inc. | 315.33M |
| Akero Therapeutics, Inc. | 957.64M |
| Belite Bio, Inc. | 274.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.02M |
| Total Liabilities (Quarterly) | 33.69M |
| Debt to Equity Ratio | -3.456 |
| Current Ratio | 0.7452 |
| Net Debt Paydown Yield | 12.06% |